Alnylam Pharmaceuticals, Inc.

IFP Advisors, Inc ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/6/2026

Shares

664

Value ($000)

264

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/6/2026	264	0.0%	664	12/31/2025
2025 Q3	2/6/2026	224	0.0%	491	9/30/2025
2025 Q2	7/24/2025	82	0.0%	200	6/30/2025
2025 Q1	5/5/2025	63	0.0%	232	3/31/2025
2024 Q4	2/4/2025	57	0.0%	241	12/31/2024
2024 Q3	2/4/2025	54	0.0%	194	9/30/2024
2024 Q2	7/30/2024	12	0.0%	49	6/30/2024
2024 Q1	7/30/2024	70	0.0%	470	3/31/2024
2023 Q4	1/9/2024	87	0.0%	456	12/31/2023
2023 Q3	10/12/2023	80	0.0%	454	9/30/2023
2023 Q2	8/4/2023	46	0.0%	453	6/30/2023
2023 Q1	4/18/2023	46	0.0%	456	3/31/2023
2022 Q4	2/7/2023	80	0.0%	659	12/31/2022
2022 Q3	11/8/2022	109	0.0%	883	9/30/2022
2022 Q1	8/8/2022	66	0.0%	526	3/31/2022
2021 Q4	1/12/2022	73	0.0%	377	12/31/2021
2021 Q3	10/6/2021	77	0.0%	370	9/30/2021
2021 Q2	7/13/2021	60	0.0%	355	6/30/2021
2021 Q1	4/30/2021	5	0.0%	35	3/31/2021
2020 Q4	1/25/2021	1	0.0%	12	12/31/2020
2020 Q3	10/29/2020	1	0.0%	13	9/30/2020
2020 Q2	8/5/2020	1	0.0%	9	6/30/2020
2020 Q1	5/12/2020	1	0.0%	9	3/31/2020
2019 Q4	1/17/2020	1	0.0%	9	12/31/2019